Bio-nanotechnology promises great advances to medicine, particularly in the diagnostics and therapeutics fields. It provides an innovative pathway to new medical devices, implants, instruments and drugs.

Until now, there has been no single organisation providing a seamless concept-to-market route for the emerging bio-nanotechnology sector. The UK’s new Bio Nano Centre takes the lead by leveraging £50M of new investment in the London Centre for Nanotechnology and the Imperial Institute for Biomedical Engineering coupled to London’s vast medical research complex to deliver rapid lab-to-prototype development services.

The Bio Nano Centre completes the value chain for companies seeking to rapidly develop, prototype and commercialise new biomedical products by providing a range of high-value infrastructure and capabilities.

For further information, please contact:

A joint venture of Imperial College London and the University College London

• Minimally invasive diagnostics
• Ultra-sensitive bio-sensors
• Systems integration of bio, micro & nano devices
• Screening of nanoscale drug-cell interaction
• Non-invasive, live-cell nanoimaging
• Application development for imaging agents and bio-markers
• Microfluidic synthesis of nanomaterials
• Implantable ‘warning’ technologies
• Engineering of bio-active materials
• Design, simulation and blueprinting of bio devices
• Self assembled bio-nano materials
• Nano-structured bio-materials and coatings
• General nano-materials and coatings
• 3D micro and nano machining
• Device and systems packaging